Werewolf Therapeutics, Inc.
HOWL- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001785530
In the last 90 days, Werewolf Therapeutics, Inc. insiders filed 0 open-market purchases and 2 sales; 45 institutions reported holding it in 13F filings for Q2 2026, worth $3.91M in total; no superinvestor holds it.
13F holders, Q4 2022
Institutional positions in Werewolf Therapeutics, Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 39
- −5 vs. Q3 2022
- Shares held
- 20.9M
- −65.1K (−0.3%) vs. Q3 2022
- Total value
- $42.8M
- −$51.6M (−54.7%) vs. Q3 2022
- New holders
- 8
- 10 more added
- Sold out
- 13
- 10 more reduced
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting HOWL on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 45 | $3.91M |
| Q1 2026 | 48 | $11.7M |
| Q4 2025 | 51 | $9.34M |
| Q3 2025 | 62 | $41.6M |
| Q2 2025 | 65 | $24.3M |
| Q1 2025 | 70 | $26.7M |
| Q4 2024 | 73 | $41.7M |
| Q3 2024 | 69 | $68.3M |
| Q2 2024 | 71 | $79.3M |
| Q1 2024 | 61 | $209.7M |
| Q4 2023 | 41 | $106.8M |
| Q3 2023 | 35 | $51.1M |
| Q2 2023 | 36 | $73.3M |
| Q1 2023 | 38 | $62.5M |
| Q4 2022 | 39 | $42.8M |
| Q3 2022 | 44 | $94.5M |
| Q2 2022 | 46 | $78.0M |
| Q1 2022 | 49 | $84.3M |
| Q4 2021 | 51 | $228.4M |
| Q3 2021 | 42 | $326.2M |
| Q2 2021 | 45 | $344.3M |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Werewolf Therapeutics, Inc.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Ra Capital Management, L.P. | 4,291,881 | $8.80M | 0.18% | 00.0% | Unchanged |
| MPM Asset Management LLC | 4,284,172 | $8.78M | 3.67% | 00.0% | Unchanged |
| MPM Oncology Impact Management LP | 2,388,011 | $4.90M | 1.27% | 00.0% | Unchanged |
| Rubric Capital Management LP | 1,835,387 | $3.76M | 0.16% | +868,508+89.8% | Added |
| Bank of America Corp | 1,533,592 | $3.14M | 0.00% | +1,530,114+43,994.1% | Added |
| PFM Health Sciences, LP | 1,293,293 | $2.65M | 0.11% | −1,522,361−54.1% | Reduced |
| Adage Capital Partners GP, L.L.C. | 1,000,597 | $2.05M | 0.00% | 00.0% | Unchanged |
| Millennium Management LLC | 838,302 | $1.72M | 0.00% | +326,694+63.9% | Added |
| Sphera Funds Management Ltd. | 626,810 | $1.28M | 0.40% | 00.0% | Unchanged |
| DC Funds, LP | 589,102 | $1.21M | 32.70% | 00.0% | Unchanged |
| Laurion Capital Management LP | 522,900 | $1.07M | 0.03% | 00.0% | Unchanged |
| Vanguard Group Inc | 448,927 | $920.3K | 0.00% | +13,671+3.1% | Added |
| Oasis Management Co Ltd. | 246,305 | $504.9K | 0.11% | 00.0% | Unchanged |
| Alyeska Investment Group, L.P. | 206,201 | $422.7K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 129,832 | $266.0K | 0.00% | +9,545+7.9% | Added |
| Tejara Capital Ltd | 128,800 | $264.0K | 0.15% | +128,800 | New |
| Jacobs Levy Equity Management, Inc | 101,221 | $207.5K | 0.00% | +101,221 | New |
| Bridgeway Capital Management, LLC | 81,711 | $167.5K | 0.00% | +40,000+95.9% | Added |
| Renaissance Technologies LLC | 78,223 | $160.0K | 0.00% | +59,923+327.4% | Added |
| BlackRock Inc. | 38,538 | $79.0K | 0.00% | −109,471−74.0% | Reduced |
| State Street Corp | 32,968 | $67.6K | 0.00% | +8,400+34.2% | Added |
| Acadian Asset Management LLC | 29,501 | $60.0K | 0.00% | +29,501 | New |
| Two Sigma Investments, LP | 27,185 | $55.7K | 0.00% | +27,185 | New |
| Ergoteles LLC | 26,501 | $54.3K | 0.00% | −88,094−76.9% | Reduced |
| Jane Street Group, LLC | 22,064 | $45.2K | 0.00% | +22,064 | New |
| Prudential Financial Inc | 21,000 | $43.0K | 0.00% | +21,000 | New |
| Chicago Partners Investment Group LLC | 10,729 | $41.2K | 0.00% | +10,729 | New |
| Northern Trust Corp | 18,439 | $37.8K | 0.00% | −114−0.6% | Reduced |
| Dimensional Fund Advisors LP | 16,206 | $33.0K | 0.00% | −9,790−37.7% | Reduced |
| Citadel Advisors LLC | 11,030 | $22.6K | 0.00% | +11,030 | New |
| Tower Research Capital LLC (TRC) | 7,146 | $15.0K | 0.00% | +615+9.4% | Added |
| Morgan Stanley | 2,512 | $5.15K | 0.00% | −7,975−76.0% | Reduced |
| UBS Group AG | 1,448 | $2.97K | 0.00% | −1,002−40.9% | Reduced |
| JPMorgan Chase & Co | 748 | $2.00K | 0.00% | −752−50.1% | Reduced |
| Financial Perspectives, Inc | 250 | $513 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 94 | $193 | 0.00% | +6+6.8% | Added |
| Citigroup Inc | 74 | $152 | 0.00% | −353−82.7% | Reduced |
| Glassman Wealth Services | 5 | $10 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 2 | $0 | 0.00% | −385−99.5% | Reduced |
| Deerfield Management Company, L.P. (Series C) | 0 | $0 | 0.00% | −958,125−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −337,073−100.0% | Sold out |
| Platinum Investment Management Ltd | 0 | $0 | 0.00% | −109,530−100.0% | Sold out |
| Caas Capital Management LP | 0 | $0 | 0.00% | −62,599−100.0% | Sold out |
| Bailard, Inc. | 0 | $0 | 0.00% | −20,200−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −19,908−100.0% | Sold out |
| Dynamic Technology Lab Private Ltd | 0 | $0 | 0.00% | −19,558−100.0% | Sold out |
| Denali Advisors LLC | 0 | $0 | 0.00% | −5,900−100.0% | Sold out |
| Oliver Lagore Vanvalin Investment Group | 0 | $0 | 0.00% | −580−100.0% | Sold out |
| China Universal Asset Management Co., Ltd. | 0 | $0 | 0.00% | −277−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −15−100.0% | Sold out |
| Daiwa Securities Group Inc. | 0 | $0 | 0.00% | −80−100.0% | Sold out |
| Ellevest, Inc. | 0 | $0 | 0.00% | −12−100.0% | Sold out |